Palatin Technologies (PTN) Assets (2011 - 2026)
Palatin Technologies' (PTN) quarterly Assets came in at $13.2 million in Q1 2026, up 254.71% on a YoY basis from $3.7 million in Q1 2025, and down 26.23% quarter-over-quarter from $17.9 million in Q4 2025.
Analysis
Palatin Technologies (PTN) Assets (2011 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Assets for 15 consecutive years, with $13.2 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 254.71% year-over-year to $13.2 million; the trailing twelve-month figure through Mar 2026 stood at $13.2 million (up 254.71% YoY), and the FY2025 full-year result was $3.3 million, down 69.59% from the prior year.
- Assets eased to $13.2 million in Q1 2026 per PTN's latest filing, from $17.9 million in the prior quarter.
- Across five years, Assets topped out at $43.8 million in Q1 2022 and bottomed at $3.3 million in Q2 2025.
- Historically, Assets has averaged $16.7 million across 5 years, with a median of $13.2 million in 2026.
- The sharpest annual moves came in 2024 and 2025: Assets sank 69.64% in 2024, then jumped 315.95% in 2025.
- Over 5 years, Assets stood at $32.0 million in 2022, then plunged by 57.61% to $13.6 million in 2023, then sank by 68.2% to $4.3 million in 2024, then surged by 315.95% to $17.9 million in 2025, then declined by 26.23% to $13.2 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $13.2 million, $17.9 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.31 Bn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | 13.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 13.23 Mn |
| Dec 31, 2025 | 17.93 Mn |
| Sep 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 3.27 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 10.74 Mn |
| Mar 31, 2024 | 11.41 Mn |
| Dec 31, 2023 | 13.55 Mn |
| Sep 30, 2023 | 11.25 Mn |
| Jun 30, 2023 | 17.94 Mn |
| Mar 31, 2023 | 25.61 Mn |
| Dec 31, 2022 | 31.98 Mn |
| Sep 30, 2022 | 27.64 Mn |
| Jun 30, 2022 | 36.07 Mn |
| Mar 31, 2022 | 43.82 Mn |
| Dec 31, 2021 | 52.99 Mn |
| Sep 30, 2021 | 59.73 Mn |
| Jun 30, 2021 | 67.30 Mn |